Pertussis Vaccine Market Report

Global and Region Pertussis Vaccine Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：221
  • REPORT CODE：GMM981075
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Pertussis vaccine is an acute respiratory infectious disease caused by Pertussis bacilli, which is mainly transmitted by carriers or early patients to infants and other susceptible people through droplets, and the infection course can be as long as 2 to 3 months. The pertussis vaccine is generally used together with vaccines for other diseases to prevent three diseases of pertussis, diphtheria, and tetanus at the same time.

    Infants and young children suffering from Pertussis may cause serious consequences, prone to suffocation, pneumonia, and other complications. In recent years, the incidence of Pertussis has increased globally. In order to strengthen the protection of newborns, governments of all countries have promoted the vaccination of Pertussis vaccines, such as increasing medical insurance and reimbursement, which has promoted the development of the Pertussis vaccines market. The strengthening of people's health awareness has also promoted the development of the Pertussis vaccine market to a certain extent.

    The report details the trend, potential and market size of Pertussis Vaccine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Pertussis Vaccinemarket, defines the market attractiveness level of Pertussis Vaccine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Pertussis Vaccine industry, describes the types of Pertussis Vaccine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pertussis Vaccine market and the development prospects and opportunities of Pertussis Vaccine industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pertussis Vaccine market in Chapter 13.

    By Player:

    • Biological Products

    • Mitsubishi Tanabe Pharma

    • GSK

    • Astellas Pharma

    • Life Sciences

    • Changchun Changsheng

    • Minhai Biotechnology

    • Beijing Tiantan

    • Biological Products

    • Wuhan Institute of

    • Minhai Biotechnology

    • Chengdu Institute of

    • Minhai Biotechnology

    By Type:

    • Whole-cell vaccines

    • Acellular vaccines

    • Others

    By End-User:

    • Children

    • Adults

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Pertussis Vaccine Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Pertussis Vaccine Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Pertussis Vaccine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Pertussis Vaccine Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Pertussis Vaccine Market Analysis and Outlook to 2022

    • 7.1 Global Pertussis Vaccine Consumption (2017-2022)

    • 7.2 United States Pertussis Vaccine Consumption (2017-2022)

    • 7.3 Europe Pertussis Vaccine Consumption (2017-2022)

    • 7.4 China Pertussis Vaccine Consumption (2017-2022)

    • 7.5 Japan Pertussis Vaccine Consumption (2017-2022)

    • 7.6 India Pertussis Vaccine Consumption (2017-2022)

    • 7.7 South Korea Pertussis Vaccine Consumption (2017-2022)

    8 Region and Country-wise Pertussis Vaccine Market Analysis and Outlook to 2028

    • 8.1 Global Pertussis Vaccine Consumption Forecast (2022-2028)

    • 8.2 United States Pertussis Vaccine Consumption Forecast (2022-2028)

    • 8.3 Europe Pertussis Vaccine Consumption Forecast (2022-2028)

    • 8.4 China Pertussis Vaccine Consumption Forecast (2022-2028)

    • 8.5 Japan Pertussis Vaccine Consumption Forecast (2022-2028)

    • 8.6 India Pertussis Vaccine Consumption Forecast (2022-2028)

    • 8.7 South Korea Pertussis Vaccine Consumption Forecast (2022-2028)

    9 Global Pertussis Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Pertussis Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Whole-cell vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Acellular vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pertussis Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Children Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Adults Consumption and Growth Rate (2017-2022)

    10 Global Pertussis Vaccine Market Outlook by Types and Applications to 2028

    • 10.1 Global Pertussis Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Whole-cell vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Acellular vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Pertussis Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Children Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Adults Consumption Forecast and Growth Rate (2022-2028)

    11 Global Pertussis Vaccine Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Pertussis Vaccine Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Pertussis Vaccine Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Pertussis Vaccine Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Pertussis Vaccine Market Competitive Analysis

    • 14.1 Biological Products

      • 14.1.1 Biological Products Company Details

      • 14.1.2 Biological Products Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Biological Products Pertussis Vaccine Product and Service

    • 14.2 Mitsubishi Tanabe Pharma

      • 14.2.1 Mitsubishi Tanabe Pharma Company Details

      • 14.2.2 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Product and Service

    • 14.3 GSK

      • 14.3.1 GSK Company Details

      • 14.3.2 GSK Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 GSK Pertussis Vaccine Product and Service

    • 14.4 Astellas Pharma

      • 14.4.1 Astellas Pharma Company Details

      • 14.4.2 Astellas Pharma Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Astellas Pharma Pertussis Vaccine Product and Service

    • 14.5 Life Sciences

      • 14.5.1 Life Sciences Company Details

      • 14.5.2 Life Sciences Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Life Sciences Pertussis Vaccine Product and Service

    • 14.6 Changchun Changsheng

      • 14.6.1 Changchun Changsheng Company Details

      • 14.6.2 Changchun Changsheng Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Changchun Changsheng Pertussis Vaccine Product and Service

    • 14.7 Minhai Biotechnology

      • 14.7.1 Minhai Biotechnology Company Details

      • 14.7.2 Minhai Biotechnology Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Minhai Biotechnology Pertussis Vaccine Product and Service

    • 14.8 Beijing Tiantan

      • 14.8.1 Beijing Tiantan Company Details

      • 14.8.2 Beijing Tiantan Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Beijing Tiantan Pertussis Vaccine Product and Service

    • 14.9 Biological Products

      • 14.9.1 Biological Products Company Details

      • 14.9.2 Biological Products Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Biological Products Pertussis Vaccine Product and Service

    • 14.10 Wuhan Institute of

      • 14.10.1 Wuhan Institute of Company Details

      • 14.10.2 Wuhan Institute of Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Wuhan Institute of Pertussis Vaccine Product and Service

    • 14.11 Minhai Biotechnology

      • 14.11.1 Minhai Biotechnology Company Details

      • 14.11.2 Minhai Biotechnology Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Minhai Biotechnology Pertussis Vaccine Product and Service

    • 14.12 Chengdu Institute of

      • 14.12.1 Chengdu Institute of Company Details

      • 14.12.2 Chengdu Institute of Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Chengdu Institute of Pertussis Vaccine Product and Service

    • 14.13 Minhai Biotechnology

      • 14.13.1 Minhai Biotechnology Company Details

      • 14.13.2 Minhai Biotechnology Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Minhai Biotechnology Pertussis Vaccine Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Pertussis Vaccine

    • Figure Pertussis Vaccine Picture

    • Table Global Pertussis Vaccine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Pertussis Vaccine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Pertussis Vaccine Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Pertussis Vaccine Consumption by Country (2017-2022)

    • Figure United States Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure China Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pertussis Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Pertussis Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pertussis Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Whole-cell vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Acellular vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Children Consumption and Growth Rate (2017-2022)

    • Figure Global Adults Consumption and Growth Rate (2017-2022)

    • Figure Global Whole-cell vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acellular vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Children Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Pertussis Vaccine Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Pertussis Vaccine Export by Region (Top 5 Countries) (2017-2028)

    • Table Biological Products (Foundation Year, Company Profile and etc.)

    • Table Biological Products Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biological Products Pertussis Vaccine Product and Service

    • Table Mitsubishi Tanabe Pharma (Foundation Year, Company Profile and etc.)

    • Table Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mitsubishi Tanabe Pharma Pertussis Vaccine Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Pertussis Vaccine Product and Service

    • Table Astellas Pharma (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Pertussis Vaccine Product and Service

    • Table Life Sciences (Foundation Year, Company Profile and etc.)

    • Table Life Sciences Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Life Sciences Pertussis Vaccine Product and Service

    • Table Changchun Changsheng (Foundation Year, Company Profile and etc.)

    • Table Changchun Changsheng Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Changchun Changsheng Pertussis Vaccine Product and Service

    • Table Minhai Biotechnology (Foundation Year, Company Profile and etc.)

    • Table Minhai Biotechnology Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Minhai Biotechnology Pertussis Vaccine Product and Service

    • Table Beijing Tiantan (Foundation Year, Company Profile and etc.)

    • Table Beijing Tiantan Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beijing Tiantan Pertussis Vaccine Product and Service

    • Table Biological Products (Foundation Year, Company Profile and etc.)

    • Table Biological Products Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biological Products Pertussis Vaccine Product and Service

    • Table Wuhan Institute of (Foundation Year, Company Profile and etc.)

    • Table Wuhan Institute of Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Wuhan Institute of Pertussis Vaccine Product and Service

    • Table Minhai Biotechnology (Foundation Year, Company Profile and etc.)

    • Table Minhai Biotechnology Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Minhai Biotechnology Pertussis Vaccine Product and Service

    • Table Chengdu Institute of (Foundation Year, Company Profile and etc.)

    • Table Chengdu Institute of Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chengdu Institute of Pertussis Vaccine Product and Service

    • Table Minhai Biotechnology (Foundation Year, Company Profile and etc.)

    • Table Minhai Biotechnology Pertussis Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Minhai Biotechnology Pertussis Vaccine Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US